We’ve got a couple of stocks that we’ve been tracking this summer coming out with noteworthy press in the early hours this morning, we’re going to want to increase our alertness level for each of them as we kick off a new trading week.
NuGene International, Inc. NUGN - NUGN is appearing in the news feed with a substantial revelation at an opportune time this morning. The stock took an absolute beating last week, and just began to find its footing off of a previous support level on Friday. At the moment the stock is extremely oversold. Coupling that with the addition of this morning’s PR announcing the company’s Q2 revenue growth of more than 150% over the prior year, conditions could be just right for a rebound. We’ll be on a sharp lookout for that possibility.
AVEO Pharmaceuticals, Inc. AVEO
AVEO stock is gapping up immensely in premarket trading on the strength of a deal the company just announced with Novartis. The potential for both a momentum play and/or a bounce play is elevated. We’ll need to see it maintain support at or above 2.20 (a previous resistance point) on any pullbacks to remain interested. With high profile news like this, it’s quite possible that it will do so.
AVEO Oncology (AVEO) today announced an exclusive, worldwide license agreement with Novartis for the development and commercialization of AVEO’s first-in-class, potent, humanized inhibitory antibody targeting growth differentiation factor 15 (GDF15), AV-380, and related antibodies>>>Full PR
Tesla Motors, Inc. TSLA – Options Idea
We’d like to submit a potential options trading idea to start the week. Morgan Stanley has raised their price target on the stock (Currently valued in the mid-$250′s) from $280 to $465, and TSLA is gapping up on the heels of that announcement. As a result, we see the potential for some intraday and/or intraweek trading opportunities in the range of TSLA Weekly $250-265 Calls.
ZU(Gapping Up), SFXE & XGTI(Both Oversold, on Bottom Watch)